Literature DB >> 28254686

Impact of inadequate initial antimicrobial therapy on mortality in patients with bacteraemic cholangitis: a retrospective cohort study.

Y Tagashira1, N Sakamoto2, T Isogai3, M Hikone2, A Kosaka2, R Chino4, M Higuchi4, Y Uehara5, H Honda6.   

Abstract

OBJECTIVES: Acute cholangitis is a common cause of bacteraemia resulting in severe sepsis or septic shock. The impact of the appropriate initial antimicrobial therapy on short-term mortality in bacteraemic cholangitis has not been well investigated.
METHODS: We conducted a retrospective cohort study of patients with bacteraemic cholangitis at two large tertiary care centres in Tokyo, Japan between 2009 and 2015. We determined the factors associated with 30-day all-cause mortality from the date of drawing the first positive blood culture, using a multivariate logistic regression analysis.
RESULTS: We identified 573 patients with bacteraemic cholangitis (median age, 77 years; male, 58.3%). The 30-day all-cause mortality rate was 6.6% (38/573). Inadequate initial antimicrobial therapy occurred in 133 (23.2%) patients. Factors associated with 30-day all-cause mortality included the Charlson co-morbidity index score >3 (adjusted odds ratio (aOR) 4.12; 95% CI 1.18-14.38), jaundice (total bilirubin >2.5 mg/dL) (aOR 3.39; 95% CI 1.46-7.89), septic shock within 48 h of the first positive blood culture (aOR 3.34; 95% CI 1.42-7.89), biliary obstruction due to hepatobiliary malignancy (aOR 8.00; 95% CI 2.92-21.97), and inadequate initial antimicrobial therapy (aOR 2.78; 95% CI 1.27-6.11).
CONCLUSIONS: Inadequate initial antimicrobial therapy was an important, modifiable determinant of survival.
Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bacteraemic cholangitis; Inadequate antimicrobial therapy; Mortality; Outcome; Treatment

Mesh:

Substances:

Year:  2017        PMID: 28254686     DOI: 10.1016/j.cmi.2017.02.027

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  7 in total

1.  Nomograms Predicting the Occurrence of Sepsis in Patients following Major Hepatobiliary and Pancreatic Surgery.

Authors:  Haoyun Zhang; Fanyu Meng; Shichun Lu
Journal:  Gastroenterol Res Pract       Date:  2020-08-01       Impact factor: 2.260

2.  Effects of Inappropriate Administration of Empirical Antibiotics on Mortality in Adults With Bacteraemia: Systematic Review and Meta-Analysis.

Authors:  Yuan-Pin Hung; Ching-Chi Lee; Wen-Chien Ko
Journal:  Front Med (Lausanne)       Date:  2022-05-30

3.  Factors Associated with Mortality in Severe Acute Cholangitis in a Moroccan Intensive Care Unit: A Retrospective Analysis of 140 Cases.

Authors:  Soumaya Touzani; Abderrahim El Bouazzaoui; Fatima Bouyarmane; Kaoutar Faraj; Nawfal Houari; Brahim Boukatta; Nabil Kanjaa
Journal:  Gastroenterol Res Pract       Date:  2021-01-27       Impact factor: 2.260

4.  Clinical characteristics of Gram-negative and Gram-positive bacterial infection in acute cholangitis: a retrospective observational study.

Authors:  Shijing Tian; Kaili Li; Hong Tang; Yan Peng; Liang Xia; Xi Wang; Xiaoying Chen; Fachun Zhou
Journal:  BMC Infect Dis       Date:  2022-03-20       Impact factor: 3.090

5.  A Retrospective Study on Bile Culture and Antibiotic Susceptibility Patterns of Patients with Biliary Tract Infections.

Authors:  Chenwei Zhao; Shanshan Liu; Xue Bai; Jitao Song; Qiaowei Fan; Jing Chen
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-13       Impact factor: 2.650

6.  Risk Factors and Predictive Score for Bacteremic Biliary Tract Infections Due to Enterococcus faecalis and Enterococcus faecium: a Multicenter Cohort Study from the PROBAC Project.

Authors:  Marco Mussa; Pedro María Martínez Pérez-Crespo; Luis Eduardo Lopez-Cortes; Pilar Retamar-Gentil; Adrián Sousa-Dominguez; Ane Josune Goikoetxea-Aguirre; José María Reguera-Iglesias; Eva León Jiménez; Isabel Fernández-Natal; Carlos Armiñanzas-Castillo; Lucía Boix-Palop; Jordi Cuquet-Pedragosa; Miguel Ángel Morán Rodríguez; Jonathan Fernandez-Suarez; Alfonso Del Arco-Jiménez; Alfredo Jóver-Saenz; Alberto Bahamonde-Carrasco; Fátima Galan-Sanchez; Juan Manuel Sánchez-Calvo; Alejandro Smithson-Amat; David Vinuesa-García; Antonio Sánchez-Porto; Inmaculada López-Hernández; Jesús Rodríguez-Baño
Journal:  Microbiol Spectr       Date:  2022-06-30

7.  Anaerobic coverage as definitive therapy does not affect clinical outcomes in community-onset bacteremic biliary tract infection without anaerobic bacteremia.

Authors:  Pei-Shan Wu; Chien Chuang; Ping-Feng Wu; Yi-Tsung Lin; Fu-Der Wang
Journal:  BMC Infect Dis       Date:  2018-06-15       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.